Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction.
Sign Up to like & getrecommendations! Published in 2021 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2021.02.012
Abstract: BACKGROUND To assess the impact of sacubitril-valsartan on apneic burden in patients with heart failure with reduced ejection fraction (HFrEF), 51 stable HFrEF patients planned for switching from an ACE-i/ARB to sacubitril-valsartan were prospectively enrolled.… read more here.
Keywords: sacubitril valsartan; treatment; heart failure; central apneas ... See more keywords
Central sleep apnea is uncommon after stroke.
Sign Up to like & getrecommendations! Published in 2020 at "Sleep medicine"
DOI: 10.1016/j.sleep.2020.08.025
Abstract: OBJECTIVE/BACKGROUND Stroke is often considered a risk factor for central sleep apnea (CSA). The goal of this study was to determine the prevalence and clinical correlates of CSA in patients with ischemic stroke. PATIENTS/METHODS In… read more here.
Keywords: ischemic stroke; central sleep; apnea; central apneas ... See more keywords